Despite a considerable improvement in antiemetic chemotherapy and the use of antiemetic prophylaxis for decades, there are still numerous cancer patients suffering from anorexia and nausea after chemotherapy, which forces them to postpone or refuse treatment. This case report is about a 66-year-old female patient diagnosed with malignant lymphoma of the small intestine who underwent right hemicolectomy. After the tumor and the colon adjacent to it were surgically removed, the patient continued to undergo chemotherapy. Chemotherapy-induced anorexia and nausea appeared but were well treated with administration of Dokhwaljihwang-tang-gamibang. During the treatment, no adverse effect related to this Korean medicine was reported. The outcome was evaluated by the functional assessment of anorexia/cachexia therapy (FAACT); the total score increased from 85 to 130 within 12 days, and the symptoms were alleviated. This improvement might suggest the feasibility of Dokhwaljihwang-tang-gamibang to help cancer patients suffering from chemotherapy-induced anorexia and nausea.
투여되는 경로가 제한적이거나, 심혈관질환, 소화기 장애 등의 부작용을 초래하며, 급성기에만 유효한 한계가 있다
따라서 항암치료 중 나타나는 식욕부진, 오심 및 구토의 예방 및 관리가 매우 중요하나, 현재까 지 발표된 항암화학요법의 후유증에 대한 양방치료엔 한계가 있다 6. 현재 보고된 항암치료 후유증 에 대한 양방치료로 5HT3RA 제제가 있는데, 투여되는 경로가 제한적이거나, 심혈관질환, 소화기 장애 등의 부작용을 초래하며, 급성기에만 유효한 한계가 있다 7. 이 밖에 일부 식욕촉진제는 암환자의 식욕부진 완화목적으로 우선적으로 사용되나, 부신기능억제를 유발할 수 있다 6.
일상 기능 및 삶의 질을 떨어뜨려 부정적인 결과를 초래하는데, 육체적 피로감, 정서적 우울함, 항암치료에 대한 스트레스로 치료에 대한 순응도 저하, 죽음에 대한 공포 및 불안 심화가 있다
항암화학요법은 수명연장과 증상 경감을 위한 주요한 암 치료법 중 하나이지만, 오심과 구토가 가 장 흔한 부작용으로, chemotherapy-induced nausea and vomiting(CINV)이라 지칭하며, CINV는 항암 치료를 받는 암환자의 70-80%에서 나타난다22. CINV 는 일상 기능 및 삶의 질을 떨어뜨려 부정적인 결과를 초래하는데, 육체적 피로감, 정서적 우울함, 항암치료에 대한 스트레스로 치료에 대한 순응도 저하, 죽음에 대한 공포 및 불안 심화가 있다4. 항구토제를 사용함으로써 오심과 구토를 다소 경감시킬 순 있지만, 설사, 두통, 아미노전이효소 상승과 같은 다른 부작용을 일으킨다 22.
암환자들은 암 질병 자체로 인한 증상뿐만 아니라, 수술, 방사선요법 및 항암화학요법 등의 치료 과정 중 수반되는 부작용에 대항하여 견뎌야 한다 1. 항암화학요법 중 가장 흔하게 나타나는 부작용으로 오심과 구토가 있는데, 암 환자의 약 45-65%에서 오심을, 15-25%에서 구토를 경험하며 2, 3, 이렇게 항암치료로 유발된 오심과 구토는 삶의 질을 현저히 떨어뜨린다 4. 또한 암 환자의 15-40%에서 식욕 부진, 영양실조, 근육량 감소가 연쇄적으로 일어나는데, 이 경우 예후가 나쁘며 조기에 사망할 수 있다5.
Cho WCS. Acupuncture and Moxibustion as an Evidence-based Therapy for Cancer. Dordrecht: Springer Netherlands: 2012.
Hesketh PJ. Chemotherapy-Induced Nausea and Vomiting. N Engl J Me 2008:358(23):2482-94.
Hilarius DL, Kloeg PH, van der Wall E, van den Heuvel JJG, Gundy CM, Aaronson NK. Chemotherapy-induced nausea and vomiting in daily clinical practice:a community hospital-based study. Support Care Cancer 2012:20(1):107-17.
Grassi L, Berardi MA, Ruffilli F, Meggiolaro E, Andritsch E, Sirgo A, et al. Role of Psychosocial Variables on Chemotherapy-Induced Nausea and Vomiting and Health-Related Quality of Life among Cancer Patients:A European Study. Psychother Psychosom 2015:84(6):339-47.
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, et al. Prognostic effect of weight loss prior tochemotherapy in cancer patients. Am J Med 1980:69(4):491-7.
Yavuzsen T, Davis MP, Walsh D, LeGrand S, Lagman R. Systematic review of the treatment of cancer-associated anorexia and weight loss. J Clin Oncol Off J Am Soc Clin Oncol 2005:23(33):8500-11.
Gilmore J, D'Amato S, Griffith N, Schwartzberg L. Recent advances in antiemetics:new formulations of 5HT3-receptor antagonists. Cancer Manag Res 2018:10:1827-57.
Cheng KC, Li YX, Cheng JT. The use of herbal medicine in cancer-related anorexia/ cachexia treatment around the world. Curr Pharm Des 2012:18(31):4819-26.
Genc F, Tan M. The effect of acupressure application on chemotherapy-induced nausea, vomiting, and anxiety in patients with breast cancer. Palliat Support Care 2015;13(02):275-84.
Huang Z, Qin Z, Yao Q, Wang Y, Liu Z. Moxibustion for Chemotherapy-Induced Nausea and Vomiting:A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2017:2017:1-11.
Inoue T, Takagi H, Owada Y, Watanabe Y, Yamaura T, Fukuhara M, et al. The efficacy of the Kampo medicine rikkunshito for chemotherapy-induced anorexia (RICH trial):study protocol for a randomized controlled trial. Trials 2017:18(1):485.
Morishige K. Traditional herbal medicine, Rikkunshito, for chemotherapy-induced nausea and vomiting. J Gynecol Oncol 2017:28(5):e57.
Ohnishi S, Watari H, Kanno M, Ohba Y, Takeuchi S, Miyaji T, et al. Additive effect of rikkunshito, an herbal medicine, on chemotherapy -induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel:results of a randomized phase II study (JORTC KMP-02). J Gynecol Oncol 2017:28(5):e44.
Cheon C, Park S, Park YL, Huang CW, Ko Y, Jang BH, et al. Sipjeondaebo-tang in patients with cancer with anorexia:a protocol for a pilot, randomised, controlled trial. BMJ Open 2016:6(5):e011212.
Yang G, Hu R, Deng A, Huang Y, Li J. Effects of Electro-Acupuncture at Zusanli, Guanyuan for Sepsis Patients and Its Mechanism through Immune Regulation. Chin J Integr Med 2016:22(3):219-24.
Su YS, Xin JJ, Yang ZK, H We, Shi H, Wang XY, et al. Effects of Different Local Moxibustion-Like Stimuli at Zusanli (ST36) and Zhongwan (CV12) on Gastric Motility and Its Underlying Receptor Mechanism. Evid Based Complement Alternat Med 2015:2015:1-8.
Markowski A, Sanford S, Pikowski J, Fauvell D, Cimino D, Caplan S. A Pilot Study Analyzing the Effects of Chinese Cupping as an Adjunct Treatment for Patients with Subacute Low Back Pain on Relieving Pain, Improving Range of Motion, and Improving Function. J Altern Complement Med 2014:20(2):113-7.
Emerich M, Braeunig M, Clement HW, Ludtke R, Huber R. Mode of action of cupping-Local metabolism and pain thresholds in neck pain patients and healthy subjects. Complement Ther Med 2014:22(1):148-58.
LeBlanc TW, Samsa GP, Wolf SP, Locke SC, Cella DF, Abernethy AP. Validation and real-world assessment of the Functional Assessment of Anorexia-Cachexia Therapy (FAACT) scale in patients with advanced non-small cell lung cancer and the cancer anorexia-cachexia syndrome (CACS). Support. Care Cancer 2015:23(8):2341-7.
Arezzo di Trifiletti A, Misino P, Giannantoni P, Giannantoni B, Cascino A, Fazi L, et al. Comparison of the performance of four different tools in diagnosing disease-associated anorexia and their relationship with nutritional, functional and clinical outcome measures in hospitalized patients. Clin Nutr 2013:32(4):527-32.
Brunelli C, Zecca E, Martini C, Campa T, Fagnoni E, Bagnasco M, et al. Comparison of numerical and verbal rating scales to measure pain exacerbations in patients with chronic cancer pain. Health Qual Life Outcomes 2010:8(1):42.
Jordan K, Gralla R, Jahn F, Molassiotis A. International antiemetic guidelines on chemotherapy induced nausea and vomiting (CINV):Content and implementation in daily routine practice. Eur J Pharmacol 2014:722:197-202.
Tina Shih YC, Xu Y, Elting LS. Costs of uncontrolled chemotherapy-induced nausea and vomiting among working-age cancer patients receiving highly or moderately emetogenic chemotherapy. Cancer 2007:110(3):678-85.
Burke TA, Wisniewski T, Ernst FR. Resource utilization and costs associated with chemotherapy -induced nausea and vomiting (CINV) following highly or moderately emetogenic chemotherapy administered in the US outpatient hospital setting. Support Care Cancer 2011:19(1):131-40.
Fearon KC, Voss AC, Hustead DS. Cancer Cachexia Study Group. Definition of cancer cachexia:effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis. Am J Clin Nutr 2006:83(6):1345-50.
Mantovani G, Madeddu C, Maccio A, Gramignano G, Lusso MR, Massa E, et al. Cancer-related anorexia/cachexia syndrome and oxidative stress:an innovative approach beyond current treatment. Cancer Epidemiol Biomark Prev Publ Am Assoc Cancer Res Cosponsored Am Soc Prev Oncol 2004:13(10):1651-9.
McClement S. Cancer anorexia-cachexia syndrome:psychological effect on the patient and family. J Wound Ostomy Cont Nurs Off Publ Wound Ostomy Cont Nurses Soc 2005:32(4):264-8.
Topkan E, Yavuz AA, Ozyilkan O. Cancer cachexia:pathophysiologic aspects and treatment options. Asian Pac J Cancer Prev APJCP 2007:8(3):445-51.
McGuire M. Nutritional care of surgical oncology patients. Semin Oncol Nurs 2000:16(2):128-34.
Aaltonen LA, Hamilton SR. World Health Organization International Agency for Research on Cancer. Pathology and genetics of tumours of the digestive system. Lyon: Oxford: IARC Press;Oxford University Press (distributor): 2000.
Herrstedt J. Nausea and emesis:still an unsolved problem in cancer patients? Support Care Cancer 2002:10(2):85-7.
Jang HS, Kim YH, Kim SH, Lee JH, Lee EJ, Song IB, et al. A Case Study of a Somatoform Disorder Patient Diagnosed with Soyangin Symptomatic Pattern of "Yin-Deficiency-Midday -Fever (陰虛午熱證)." J Sasang Const Med 2008:20(2):119-28.
Kim HS, Kim MK, Lee M, Kwon BS, Suh DH, Song YS. Effect of Red Ginseng on Genotoxicity and Health-Related Quality of Life after Adjuvant Chemotherapy in Patients with Epithelial Ovarian Cancer: A Randomized, Double Blind, Placebo-Controlled Trial. Nutrients 2017:9(7):772.
Wang CZ, Yuan CS. Potential Role of Ginseng in the Treatment of Colorectal Cancer. Am J Chin Med 2008:36(6):1019-28.
Ma L. Acupuncture as a complementary therapy in chemotherapy-induced nausea and vomiting. Proc Bayl Univ Med Cent 2009:22(2):138-41.
Jeon JH, Cho CK, Park SJ, Kang HJ, Kim K, Jung IC, et al. A Feasibility Study of Moxibustion for Treating Anorexia and Improving Quality of Life in Patients With Metastatic Cancer: A Randomized Sham-Controlled Trial. Integr Cancer Ther 2017:16(1):118-25.